Neoplus Criticare Private Limited

Neoplus Criticare Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U85100MH2003PTC140952 Incorporated 18 June 2003 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2024
₹2.15 Cr
▼ 11% YoY
Net profit · FY 2024
₹3.3 Lakh
Net margin 1.5%
EBITDA · FY 2024
₹8.15 Lakh
EBITDA margin 3.8%
Authorised capital
₹24 Lakh
Registered with MCA
Paid-up capital
₹14 Lakh
Issued & subscribed
Company age
23 yrs
Est. 2003
Employees · EPFO
12
Provident fund records
Directors on board
6
As per MCA filings

About Neoplus Criticare Private Limited

Data last updated:

Neoplus Criticare Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the hospital services segment of the healthcare sector. It was incorporated on 18 June 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2003PTC140952.

The company has an authorised share capital of ₹24 Lakh and a paid-up capital of ₹14 Lakh. It is led by directors including Sanjay Bhagwant Prabhu and Prashant Ramesh Gandhi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 1 – 2 Madhav Building New Link Road Near Don Bosco Signal Borivli (West), Mumbai, Maharashtra, India – 400091.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.15 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹3.3 Lakh (net margin 1.5%) and EBITDA of ₹8.15 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 2% over five years.

The company has about 12 employees on its provident fund (EPFO) records.

Court records list 2 cases involving the company, including 2 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U85100MH2003PTC140952
Registration Number 140952
Incorporation Date 18 June 2003
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Neoplus Criticare Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop No 1 – 2 Madhav Building New Link Road Near Don Bosco Signal Borivli (West), Mumbai, Maharashtra, India – 400091
  • Industry
    Healthcare, Hospital Services

To see the full contact details of Neoplus Criticare Private Limited, buy the company report.

Comprehensive company report
Neoplus Criticare Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Neoplus Criticare is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Neoplus Criticare Private Limited, buy the company report.

Financials of Neoplus Criticare Private Limited

FY 2025 filings available

Neoplus Criticare Private Limited reported revenue of ₹2.15 Cr (down 11% YoY) for FY 2024.

Revenue · FY 2024
₹2.15 Cr ▼ 11%
Net profit · FY 2024
₹3.3 Lakh margin 1.5%
EBITDA · FY 2024
₹8.15 Lakh margin 3.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 28%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 69%
3 years · compounded
▲ 31%
5 years · compounded
▲ 40%

Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹8.15 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.3 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.8%
Net Profit Margin1.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Neoplus Criticare Private Limited, buy the company report.

Board of directors of Neoplus Criticare Private Limited

Neoplus Criticare has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanjay Bhagwant PrabhuDirector18 Jun 200323 Years 4 MonthsCurrent
Prashant Ramesh GandhiDirector18 Jun 200323 Years 4 MonthsCurrent
Devang Kalyanbhai ShahDirector18 Jun 200323 Years 4 MonthsCurrent
Charu SuraiyaDirector18 Jun 200323 Years 4 MonthsCurrent
Mukund Chandulal PatelDirector18 Jun 200323 Years 4 MonthsCurrent
Kamlesh Kumar ShrivastavaDirector18 Jun 200323 Years 4 MonthsCurrent

Auditor

Neoplus Criticare Private Limited is audited by MUKESH C. BHATT for the financial year 2017.

Auditor firmFinancial yearFirm registration number
MUKESH C. BHATTFY 201714092

Shareholding

The shareholding of Neoplus Criticare Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Neoplus Criticare Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Neoplus Criticare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Neoplus Criticare Private Limited has a workforce of 12 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
12
Active EPFO establishments
1

GST

No GST registration is on our record for Neoplus Criticare Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Neoplus Criticare Private Limited has 8 board changes on record since 2003: 6 appointments and 2 cessations. The latest: Vasant Anant Khatav ceased to be Director on 21 Apr 2010.

AGM
Neoplus Criticare Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Neoplus Criticare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Vasant Anant Khatav ceased to be Director.
Ceased
Sharadchandra Mahadeo Pendse ceased to be Director.
Appointed
Charu Suraiya was appointed as Director.
Appointed
Devang Kalyanbhai Shah was appointed as Director.
Appointed
Kamlesh Kumar Shrivastava was appointed as Director.
Appointed
Mukund Chandulal Patel was appointed as Director.
Appointed
Prashant Ramesh Gandhi was appointed as Director.
Appointed
Sanjay Bhagwant Prabhu was appointed as Director.
Incorporation
18 Jun 2003
Neoplus Criticare Private Limited was registered on 18 Jun 2003 with Roc Mumbai & aged 23 years 4 months as per MCA records.

Frequently asked questions

Neoplus Criticare is an active private limited company based in Mumbai, Maharashtra, India. The company works in hospital services, within the healthcare industry. It was incorporated on 18 June 2003 (23+ years old) and is registered under CIN U85100MH2003PTC140952.

Neoplus Criticare has 6 current directors:

The latest financial statements of Neoplus Criticare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Neoplus Criticare is U85100MH2003PTC140952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Neoplus Criticare has 2 court cases on record: 2 filed against it.

Neoplus Criticare was incorporated on 18 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.

Vasant Anant Khatav ceased to be Director on 21 Apr 2010. Sharadchandra Mahadeo Pendse ceased to be Director on 01 Apr 2009. Charu Suraiya was appointed as Director on 18 Jun 2003. Neoplus Criticare has 8 board changes on record in total.

The registered office of Neoplus Criticare is at Shop No 1 – 2 Madhav Building New Link Road Near Don Bosco Signal Borivli West, Mumbai, Maharashtra, India – 400091.

Neoplus Criticare operates in the healthcare industry, in the hospital services segment.

The compliance status of Neoplus Criticare is compliant as of 12 July 2026. The company is actively filing with the Registrar of Companies.